Zinc Acetate Hydrate Supplementation versus Polaprezinc Supplementation for Improving Hypozincemia in Hemodialysis Patients: A Randomized Clinical Trial.


Journal

International journal of nephrology
ISSN: 2090-214X
Titre abrégé: Int J Nephrol
Pays: United States
ID NLM: 101546753

Informations de publication

Date de publication:
2023
Historique:
received: 14 12 2022
revised: 15 09 2023
accepted: 23 09 2023
medline: 16 10 2023
pubmed: 16 10 2023
entrez: 16 10 2023
Statut: epublish

Résumé

Zinc supplementation may ameliorate zinc deficiency in maintenance hemodialysis patients; however, no standard protocol has been established. This study aimed to investigate the effects of zinc acetate hydrate (ZAH) and polaprezinc (PPZ) as zinc supplements in hemodialysis patients. We enrolled 75 hemodialysis patients with serum zinc levels <60 

Identifiants

pubmed: 37840640
doi: 10.1155/2023/2403755
pmc: PMC10569889
doi:

Types de publication

Journal Article

Langues

eng

Pagination

2403755

Informations de copyright

Copyright © 2023 Etsuko Kumagai et al.

Déclaration de conflit d'intérêts

The authors declare no conflicts of interest regarding the publication of this paper.

Références

Nutrients. 2020 Mar 13;12(3):
pubmed: 32183116
Adv Nutr. 2020 Mar 1;11(2):398-411
pubmed: 31504083
Clin Exp Nephrol. 2020 Oct;24(10):955-962
pubmed: 32557260
Int J Mol Sci. 2020 Apr 22;21(8):
pubmed: 32331308
BMC Nephrol. 2015 Apr 11;16:52
pubmed: 25884981
Biomed Res Int. 2017;2017:1024769
pubmed: 29457023
Nephrol Dial Transplant. 2007 May;22 Suppl 2:ii45-87
pubmed: 17507426
Immun Ageing. 2022 Aug 30;19(1):40
pubmed: 36042501
Am J Kidney Dis. 2020 Sep;76(3 Suppl 1):S1-S107
pubmed: 32829751
Toxins (Basel). 2022 Oct 31;14(11):
pubmed: 36355996
Int J Nephrol Renovasc Dis. 2015 Dec 10;8:159-63
pubmed: 26677341
Ther Apher Dial. 2020 Oct;24(5):568-577
pubmed: 31794152
J Res Med Sci. 2021 Jun 30;26:42
pubmed: 34484374

Auteurs

Etsuko Kumagai (E)

Kenwakai Hospital, 1936, Kanaenakadaira, Iida, Nagano 395-0801, Japan.
Department of Innovative Medicine, Osaka Medical College, 2-7, Daigaku-cho, Takatsuki, Osaka 569-8686, Japan.

Kazuhiro Furumachi (K)

Kenwakai Hospital, 1936, Kanaenakadaira, Iida, Nagano 395-0801, Japan.

Akihiro Kurihara (A)

Japanese Red Cross Society Shimoina Red Cross Hospital, 3159-1, Motoojima, Matsukawa-machi, Shimoina-gun, Nagano 399-3303, Japan.

Ken Hosokawa (K)

Shimoina Kosei Hospital, 481-13, Yoshida, Takamori-machi, Shimoina-gun, Nagano 399-3102, Japan.

Keiko Hosohata (K)

Education and Research Center for Clinical Pharmacy, Osaka University of Pharmaceutical Sciences, 4-20-1, Nasahara, Takatsuki, Osaka 569-1094, Japan.

Shinji Takai (S)

Department of Innovative Medicine, Osaka Medical College, 2-7, Daigaku-cho, Takatsuki, Osaka 569-8686, Japan.

Classifications MeSH